Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Peptimmune
company
About
Peptimmune is a drug company focused on the rare skin disease pemphigus vulgaris.
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $41.20M
- Industries
- Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 1, 2002
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Peptimmune is a privately held clinical stage biotechnology company focused on utilizing both novel and proven technologies to improve the therapeutic management of chronic autoimmune and metabolic disorders. The company is developing second generation therapeutics that are expected to result in safer and more effective products for obesity, multiple sclerosis, rheumatoid arthritis and pemphigus vulgaris.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$58.29M
Peptimmune has raised a total of
$58.29M
in funding over 2 rounds. Their latest funding was raised on
Jul 17, 2008 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 17, 2008 | Series D | $8.90M | 1 | — | — | Detail |
| Jan 17, 2008 | Series D | $8.19M | 1 | — | — | Detail |
| Mar 12, 2003 | Series B | $41.20M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Peptimmune is funded by 2 investors.
Boston Medical Investors
and Hunt Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
